Quinoxaline Nucleus: A Promising Scaffold in Anti-cancer Drug Discovery

Title:Quinoxaline Nucleus: A Promising Scaffold in Anti-cancer Drug Discovery

Volume: 16 Issue: 10

Author(s): Alessandra C. Pinheiro, Thais C. Mendonça Nogueira and Marcus V.N. de Souza

Affiliation:

Keywords: Cancer, drug discovery, synthesis, quinoxaline, heterocyclic compounds, biological activity.

Abstract: Heterocyclic compounds are a class of substances, which play a critical role in modern drug discovery being incorporated in the structure of a large variety of drugs used in many different types of diseases. Quinoxaline is an important heterocyclic nucleus with a wide spectrum of biological activities, and recently much attention has been found on anticancer drug discovery based on this class. Owing to the importance of this system, the aim of this review is to provide an update on the synthesis and anticancer activity of quinoxaline derivatives covering articles published between 2010 and 2015.

Cite this article as:

Pinheiro C. Alessandra, Mendonça Nogueira C. Thais and de Souza V.N. Marcus, Quinoxaline Nucleus: A Promising Scaffold in Anti-cancer Drug Discovery, Anti-Cancer Agents in Medicinal Chemistry 2016; 16 (10) . https://dx.doi.org/10.2174/1871520616666160622090839